|
WO1999051208A1
(en)
|
1998-04-03 |
1999-10-14 |
Bm Research A/S |
Controlled release composition
|
|
US20040234602A1
(en)
|
2001-09-21 |
2004-11-25 |
Gina Fischer |
Polymer release system
|
|
EP1429744A1
(en)
|
2001-09-21 |
2004-06-23 |
Egalet A/S |
Morphine polymer release system
|
|
ATE381924T1
(de)
*
|
2001-09-21 |
2008-01-15 |
Egalet As |
Feste dispersionen mit kontrollierter freisetzung von carvedilol
|
|
US8101209B2
(en)
*
|
2001-10-09 |
2012-01-24 |
Flamel Technologies |
Microparticulate oral galenical form for the delayed and controlled release of pharmaceutical active principles
|
|
AU2003231283A1
(en)
*
|
2002-04-30 |
2003-11-17 |
Sb Pharmco Puerto Rico Inc. |
Carvedilol monocitrate monohydrate
|
|
KR101468827B1
(ko)
|
2002-06-27 |
2014-12-03 |
스미스클라인 비이참 (코르크) 리미티드 |
카베딜롤 인산염 및(또는) 그의 용매화물, 상응하는 조성물, 및(또는) 치료 방법
|
|
JP2005533822A
(ja)
|
2002-06-27 |
2005-11-10 |
エスビー・ファルムコ・プエルト・リコ・インコーポレイテッド |
臭化水素酸カルベジロール
|
|
AU2003275953A1
(en)
*
|
2002-11-08 |
2004-06-07 |
Egalet A/S |
Controlled release carvedilol compositions
|
|
WO2004047837A2
(en)
*
|
2002-11-22 |
2004-06-10 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem |
Beta-blockers having antioxidant and nitric oxide-donor activity
|
|
EP1610768B1
(en)
*
|
2003-03-26 |
2008-07-02 |
Egalet A/S |
Matrix compositions for controlled delivery of drug substances
|
|
WO2004084868A1
(en)
|
2003-03-26 |
2004-10-07 |
Egalet A/S |
Morphine controlled release system
|
|
WO2004093850A1
(en)
*
|
2003-04-24 |
2004-11-04 |
Jagotec Ag |
Tablet with coloured core
|
|
US7260685B2
(en)
|
2003-06-20 |
2007-08-21 |
Micron Technology, Inc. |
Memory hub and access method having internal prefetch buffers
|
|
ES2655435T3
(es)
*
|
2003-09-12 |
2018-02-20 |
Amgen Inc. |
Formulación de disolución rápida de cinacalcet
|
|
US7120743B2
(en)
|
2003-10-20 |
2006-10-10 |
Micron Technology, Inc. |
Arbitration system and method for memory responses in a hub-based memory system
|
|
EP1686986A4
(en)
|
2003-11-25 |
2009-05-27 |
Sb Pharmco Inc |
CARVEDILOL SALTS, CORRESPONDING COMPOSITIONS, METHODS OF ADMINISTRATION AND / OR TREATMENT
|
|
US8734850B2
(en)
|
2003-11-25 |
2014-05-27 |
Flamel Technologies |
Oral medicinal product with modified release of at least one active principle in multimicrocapsular form
|
|
JP2007512350A
(ja)
*
|
2003-11-25 |
2007-05-17 |
エスビー・ファルムコ・プエルト・リコ・インコーポレイテッド |
カルベジロール組成物の治療および送達方法
|
|
EP1750717B1
(en)
*
|
2004-02-11 |
2017-07-19 |
Rubicon Research Private Limited |
Controlled release pharmaceutical compositions with improved bioavailability
|
|
NZ563846A
(en)
*
|
2005-06-03 |
2010-03-26 |
Egalet As |
A drug delivery system for delivering active substances dispersed in a dispersion medium
|
|
US8367112B2
(en)
*
|
2006-02-28 |
2013-02-05 |
Alkermes Pharma Ireland Limited |
Nanoparticulate carverdilol formulations
|
|
US8703804B2
(en)
|
2006-03-26 |
2014-04-22 |
Uti Limited Partnership |
Ryanodine receptor inhibitors and methods relating thereto
|
|
UA96457C2
(ru)
|
2006-08-03 |
2011-11-10 |
Нитек Фарма Аг |
Лечение ревматоидного артрита глюкокортикоидами с отсроченным высвобождением
|
|
WO2008070072A2
(en)
*
|
2006-12-01 |
2008-06-12 |
Mutual Pharmaceutical Company, Inc. |
Carvedilol forms, compositions, and methods of preparation thereof
|
|
US20090028935A1
(en)
*
|
2006-12-01 |
2009-01-29 |
Kristin Arnold |
Carvedilol forms, compositions, and methods of preparation thereof
|
|
EP2104493A2
(en)
*
|
2007-01-16 |
2009-09-30 |
Egalet A/S |
Use of i) a polyglycol and n) an active drug substance for the preparation of a pharmaceutical composition for i) mitigating the risk of alcohol induced dose dumping and/or ii) reducing the risk of drug abuse
|
|
WO2008114276A1
(en)
*
|
2007-03-16 |
2008-09-25 |
Lupin Limited |
Novel oral controlled release composition of carvedilol
|
|
BRPI0701904A2
(pt)
*
|
2007-04-27 |
2008-12-09 |
Libbs Farmaceutica Ltda |
forma farmacÊutica de liberaÇço controlada de princÍpios ativos com solubilidade dependente do baixo ph do meio e processo para preparar a forma farmacÊutica
|
|
US8821928B2
(en)
|
2007-06-04 |
2014-09-02 |
Egalet Ltd. |
Controlled release pharmaceutical compositions for prolonged effect
|
|
AU2010207740B2
(en)
*
|
2009-01-26 |
2016-06-16 |
Nitec Pharma Ag |
Delayed-release glucocorticoid treatment of asthma
|
|
CA2751667C
(en)
|
2009-02-06 |
2016-12-13 |
Egalet Ltd. |
Immediate release composition resistant to abuse by intake of alcohol
|
|
NZ597283A
(en)
|
2009-06-24 |
2013-07-26 |
Egalet Ltd |
Controlled release formulations
|
|
TWI415604B
(zh)
*
|
2009-09-29 |
2013-11-21 |
Tsh Biopharm Corp Ltd |
調控釋放卡菲蒂羅劑型
|
|
ES2706880T3
(es)
|
2010-02-22 |
2019-04-01 |
Daiichi Sankyo Co Ltd |
Preparación sólida de liberación sostenida para uso oral
|
|
JP5714562B2
(ja)
*
|
2010-02-22 |
2015-05-07 |
第一三共株式会社 |
経口用徐放性固形製剤
|
|
AU2013285988A1
(en)
|
2012-07-06 |
2015-02-12 |
Egalet Ltd. |
Abuse deterrent pharmaceutical compositions for controlled release
|
|
CA2883077C
(en)
|
2012-09-03 |
2017-03-07 |
Daiichi Sankyo Company, Limited |
Hydromorphone hydrochloride-containing oral sustained-release pharmaceutical composition
|
|
KR102241487B1
(ko)
|
2013-02-20 |
2021-04-16 |
주식회사 종근당 |
제어방출 펠릿으로 된 약제학적 조성물
|
|
KR102158339B1
(ko)
|
2016-02-05 |
2020-09-21 |
삼진제약주식회사 |
인습성이 개선된 카르베딜롤 속방성 제제
|